Here are five things to know:
1. Dr. Golish is a spinal surgeon, medical device and data scientist who comes with extensive experience as a healthcare administrator and executive.
2. Dr. Golish’s role will be to support Medacta’s spine product development and commercial activities.
3. In a statement, Francesco Siccardi, Medacta’s executive vice president, said the company values Dr. Golish’s “dedication to patient safety and the role that medical device innovation can play in improving life.”
4. Medacta enjoyed a successful 2016, when the spine division experienced underwent 140 percent sales growth. The company has grown at least 24 percent in the last five consecutive quarters.
5. Medacta released three new products in 2016, including the MySpine Low Profile Guide, which Dr. Golish used soon after it passed FDA clearance.
More articles on medical devices:
Zimmer Biomet enjoys a 106% increase in 2016 earnings — 8 things to know
5 key points on Trump’s meeting with pharma execs
FDA premarket approvals dropped 51% in 2016 — but 2017 shaping up differently: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
